Simcere Pharmaceutical Group Reports Preliminary Unaudited Fourth Quarter and Full Year 2012 Results

NANJING, China, March 7, 2013 — NANJING, China, March 7, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2012.
MORE ON THIS TOPIC